Affordable Care Act Volume Shifts: Impacts on Health Care Valuation
Health Care Valuation Services
Never miss a thing.
Sign up to receive our insights newsletter.

Providers entered 2026 with strong operating momentum, but a meaningful structural payer shift is beginning to surface. The expiration of enhanced Affordable Care Act (ACA) exchange subsidies is expected to reduce enrollment meaningfully, affecting volumes, reimbursement mix and profit margins across portions of the health care system.
Although the official statistics regarding ACA enrollment decreases won’t be released until summer 2026, large operators like HCA Healthcare and Tenet Healthcare have been able to quantify the financial impact in their forward guidance.
By the Numbers
- HCA Healthcare expects a 15%-20% decline in health insurance exchange volumes in 2026 and has identified this trend as a material headwind to performance.
- HCA guided to $850 million to $1.35 billion of 2026 headwinds tied to ACA reforms and Medicaid payment pressure, partially offset by internal cost-savings initiatives.
- Tenet Healthcare estimated a $250 million negative impact to 2026 adjusted EBITDA from the expiration of enhanced exchange premium tax credits, assuming approximately a 20% drop in exchange enrollment.
- Tenet also highlighted elevated exposure in states such as Arizona, Michigan and California, where ACA exchange participation has historically been higher.
Why it Matters: Payer Mix Shifts and Margin Pressure
- Exchange patients occupy a critical middle ground within the payer mix. Reimbursement levels are meaningfully above uninsured patients but below commercial insurance, making exchange volumes disproportionately important to margin stability.
- HCA management emphasized proactive mitigation efforts, noting that the company is implementing operational and cost initiatives to offset anticipated exchange-related headwinds.
- Tenet framed the issue primarily as a policy-driven payer mix shift rather than a demand issue, underscoring that higher-acuity services and ambulatory growth remain intact despite enrollment pressure.
- The net effect is a widening performance gap: operators with diversified portfolios, strong commercial exposure and meaningful ambulatory scale are better positioned to absorb the impact, while assets with heavier reliance on exchange and Medicaid volumes face increased margin volatility.
Health Care Valuation Takeaways
- Payer mix assumptions require heightened scrutiny in 2026 valuation models. Reliance on trailing EBITDA without normalization for exchange enrollment declines may overstate sustainable earnings power.
- Geographic exposure matters. Assets located in high ACA penetration states warrant higher risk adjustments or expanded scenario analysis.
- Cost structure flexibility is increasingly a key value driver. Systems with credible labor management strategies and scale-driven efficiencies demonstrate greater earnings durability in an unstable payer mix environment.
- Ambulatory and ambulatory surgery centers (ASCs) exposure provides downside protection. Diversified care-site strategies help mitigate inpatient margin pressure and continue to support stronger valuation multiples.
As ACA-related enrollment shifts begin to take hold, valuation assumptions and operating expectations may require a reset. Understanding how payer mix changes influence earnings quality will be critical in the year ahead. To learn how these trends could impact your organization or transaction strategy, contact us. We’re here to help.
©2026